Nurexone Biologic Inc NRXBF
$0.46 $0.02 (5.01%) 1D
Last Updated: Aug 21, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
NRXBF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Nurexone Biologic Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Nurexone Biologic Inc. Stock Analysis NRXBF
United States Health Care Nano Cap NurExone Biologic, Inc. is a pharmaceutical company, which engages in the development and commercialization of biological extracellular vesicles-based technology drug platforms. The company is headquartered in Haifa, Haifa. The company went IPO on 2012-05-08. The firm is engaged in developing a platform for biologically guided exosome-based therapies to be delivered, minimally invasive, to patients who have suffered central nervous system injuries. The Company’s flagship product, ExoPTEN for acute spinal cord injury, uses exosomes loaded with a specific and sIRNA sequence as the active pharmaceutical ingredient. Its ExoTherapy is a platform for developing exosome-based therapies. The NurExone platform technology is expected to offer solutions to drug companies interested in minimally invasive targeted drug delivery for other indications. The firm focuses on research and development of pharmaceutical technologies.
Nurexone Biologic Inc (NRXBF) Chart
Financial Metrics & Statements of Nurexone Biologic Inc (NRXBF)
FAQ's for Nurexone Biologic Inc (NRXBF)
- As of August 2026, Nurexone Biologic Inc NRXBF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Nurexone Biologic Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Nurexone Biologic Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Nurexone Biologic Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Nurexone Biologic Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Nurexone Biologic Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Nurexone Biologic Inc (NRXBF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
